STACK DAVID M
Insider CIK 1204788 · CHMA Director · PCRX President, CEO and Chairman, Director · AMRN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2023-06-14 | 2023-06-16 | 245,400 | — | $0 | 245,400 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2023-06-14 | 2023-06-16 | 32,700 | — | $0 | 186,481 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2023-06-07 | 2023-06-07 | 5,326 | $37.87 | $201.7K | 153,781 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2023-06-06 | 2023-06-07 | 5,058 | $38.99 | $197.2K | 159,107 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2022-06-08 | 2022-06-08 | 160,900 | — | $0 | 160,900 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-06-08 | 2022-06-08 | 5,006 | $60.33 | $302.0K | 144,034 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-06-08 | 2022-06-08 | 501 | $61.96 | $31.0K | 142,251 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-06-08 | 2022-06-08 | 1,282 | $61.31 | $78.6K | 142,752 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2022-06-08 | 2022-06-08 | 21,500 | — | $0 | 163,751 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-06-08 | 2022-06-08 | 7,039 | $59.10 | $416.0K | 149,040 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2022-06-06 | 2022-06-08 | 11,965 | $61.37 | $734.3K | 156,079 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-04-28 | 2022-05-02 | 22,500 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-04-28 | 2022-05-02 | 22,500 | $10.81 | $243.2K | 168,044 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-03-31 | 2022-04-05 | 22,500 | — | $0 | 22,500 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-03-31 | 2022-04-05 | 22,500 | $10.81 | $243.2K | 145,544 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-01-25 | 2022-01-27 | 13,670 | — | $0 | 45,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-01-25 | 2022-01-27 | 13,670 | $10.81 | $147.8K | 123,044 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2022-01-11 | 2022-01-13 | 15,000 | — | $0 | 58,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2022-01-11 | 2022-01-13 | 15,000 | $10.81 | $162.2K | 109,374 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2021-11-16 | 2021-11-18 | 15,000 | — | $0 | 73,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2021-11-16 | 2021-11-18 | 15,000 | $10.81 | $162.2K | 94,085 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 72,683 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 91,954 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer | 2021-08-05 | 2021-08-05 | 25,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 36,000 | — | $0 | 36,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2021-06-14 | 2021-06-16 | 45,953 | — | $0 | 45,953 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2021-06-09 | 2021-06-11 | 133,400 | — | $0 | 133,400 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2021-06-09 | 2021-06-11 | 17,800 | — | $0 | 78,956 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2021-06-04 | 2021-06-07 | 10,000 | $4.54 | $45.4K | 40,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-06-04 | 2021-06-08 | 14,905 | $61.04 | $909.8K | 61,156 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2021-06-03 | 2021-06-07 | 5,000 | $4.62 | $23.1K | 30,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2021-05-12 | 2021-05-13 | 21,250 | — | $0 | 88,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 3,611 | $62.41 | $225.4K | 76,061 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 14,669 | $62.08 | $910.7K | 79,672 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-05-12 | 2021-05-13 | 2,970 | $60.76 | $180.5K | 94,341 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2021-05-12 | 2021-05-13 | 21,250 | $10.81 | $229.7K | 97,311 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2021-05-11 | 2021-05-13 | 21,250 | — | $0 | 109,920 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2021-05-11 | 2021-05-13 | 21,250 | $10.81 | $229.7K | 97,311 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 13,318 | $60.78 | $809.5K | 83,993 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-05-11 | 2021-05-13 | 7,932 | $61.19 | $485.4K | 76,061 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | G Gift | 2021-03-24 | 2021-05-13 | 1,080 | — | $0 | 97,273 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2021-02-03 | 2021-02-04 | 21,250 | — | $0 | 131,170 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-02-03 | 2021-02-04 | 14,350 | $71.42 | $1.02M | 76,061 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-02-03 | 2021-02-04 | 6,900 | $70.78 | $488.4K | 90,411 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2021-02-03 | 2021-02-04 | 21,250 | $10.81 | $229.7K | 97,311 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2021-02-02 | 2021-02-04 | 21,250 | — | $0 | 152,420 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 4,100 | $70.20 | $287.8K | 76,061 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 14,250 | $69.38 | $988.7K | 80,161 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 2,900 | $68.41 | $198.4K | 94,411 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2021-02-02 | 2021-02-04 | 21,250 | $10.81 | $229.7K | 97,311 | SEC↗ |
| CHMA CHIASMA, INC | P Buy | 2020-11-30 | 2020-12-01 | 25,000 | $4.27 | $106.7K | 25,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | P Buy | 2020-11-30 | 2020-12-02 | 25,000 | $4.86 | $121.5K | 25,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-10-16 | 2020-10-16 | 30,000 | — | $0 | 173,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-10-16 | 2020-10-16 | 30,000 | $10.81 | $324.3K | 203,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-10-16 | 2020-10-16 | 30,000 | $55.56 | $1.67M | 173,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-10-15 | 2020-10-16 | 30,000 | — | $0 | 203,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-10-15 | 2020-10-16 | 30,000 | $10.81 | $324.3K | 203,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-10-15 | 2020-10-16 | 30,000 | $55.00 | $1.65M | 173,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-10-14 | 2020-10-16 | 30,000 | — | $0 | 233,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-10-14 | 2020-10-16 | 30,000 | $10.81 | $324.3K | 203,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-10-14 | 2020-10-16 | 30,000 | $55.53 | $1.67M | 173,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-08-17 | 2020-08-19 | 3,217 | $62.34 | $200.5K | 173,377 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-08-17 | 2020-08-19 | 11,783 | $61.79 | $728.1K | 176,594 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-07-15 | 2020-07-17 | 12,000 | $56.88 | $682.6K | 188,377 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 27,191 | — | $0 | 27,191 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2020-07-13 | 2020-07-15 | 34,805 | — | $0 | 34,805 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2020-06-11 | 2020-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 275,000 | — | $0 | 275,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2020-06-09 | 2020-06-11 | 33,300 | — | $0 | 200,209 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-06-08 | 2020-06-08 | 15,390 | $48.08 | $740.0K | 168,630 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-06-08 | 2020-06-08 | 1,721 | $48.49 | $83.5K | 166,909 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-06-04 | 2020-06-08 | 14,314 | $46.33 | $663.2K | 184,020 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-02-21 | 2020-02-25 | 16,356 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-02-21 | 2020-02-25 | 19,500 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-02-21 | 2020-02-25 | 16,356 | $5.49 | $89.8K | 198,334 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-02-21 | 2020-02-25 | 19,500 | $1.61 | $31.4K | 181,978 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2020-01-15 | 2020-01-17 | 25,000 | — | $0 | 243,129 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-01-15 | 2020-01-17 | 1,975 | $43.48 | $85.9K | 1,208 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2020-01-15 | 2020-01-17 | 23,025 | $42.61 | $981.1K | 3,183 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2020-01-15 | 2020-01-17 | 25,000 | $10.81 | $270.3K | 26,208 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-12-26 | 2019-12-30 | 10,000 | — | $0 | 16,356 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-12-26 | 2019-12-30 | 10,000 | — | $0 | 19,500 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-12-26 | 2019-12-30 | 10,000 | $5.49 | $54.9K | 162,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-12-26 | 2019-12-30 | 10,000 | $1.61 | $16.1K | 152,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-11-15 | 2019-11-19 | 25,000 | — | $0 | 288,670 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-11-15 | 2019-11-19 | 25,000 | $42.81 | $1.07M | 1,208 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-11-15 | 2019-11-19 | 45,000 | $42.81 | $1.93M | 142,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-11-15 | 2019-11-19 | 25,000 | $10.81 | $270.3K | 26,208 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-10-02 | 2019-10-04 | 10,000 | — | $0 | 26,356 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-10-02 | 2019-10-04 | 7,000 | — | $0 | 29,500 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-10-02 | 2019-10-04 | 7,000 | $1.61 | $11.3K | 177,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-10-02 | 2019-10-04 | 10,000 | $5.49 | $54.9K | 187,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-09-18 | 2019-09-20 | 7,500 | — | $0 | 36,500 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-09-18 | 2019-09-20 | 6,500 | — | $0 | 36,356 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-09-18 | 2019-09-20 | 6,500 | $5.49 | $35.7K | 170,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-09-18 | 2019-09-20 | 7,500 | $1.61 | $12.1K | 163,799 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-08-15 | 2019-08-16 | 12,849 | — | $0 | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 10,458 | $39.05 | $408.4K | 158,690 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-08-15 | 2019-08-16 | 12,849 | $10.81 | $138.9K | 169,148 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-08-15 | 2019-08-16 | 2,391 | $39.61 | $94.7K | 156,299 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-07-11 | 2019-07-12 | 28,847 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-07-11 | 2019-07-12 | 23,144 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-07-11 | 2019-07-12 | 23,144 | $2.50 | $57.9K | 23,144 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-07-11 | 2019-07-12 | 28,847 | $2.19 | $63.2K | 51,991 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-07-11 | 2019-07-12 | 51,991 | $22.28 | $1.16M | 0 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-07-08 | 2019-07-10 | 700 | $43.42 | $30.4K | 156,299 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-07-08 | 2019-07-10 | 12,415 | $42.85 | $532.0K | 156,999 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2019-06-13 | 2019-06-17 | 13,000 | — | $0 | 13,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 44,000 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise deriv | 2019-06-11 | 2019-06-13 | 9,000 | — | $0 | 42,856 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-06-11 | 2019-06-13 | 15,000 | $1.61 | $24.1K | 160,231 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | M Exercise | 2019-06-11 | 2019-06-13 | 9,000 | $5.49 | $49.4K | 169,231 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award deriv | 2019-06-05 | 2019-06-06 | 142,100 | — | $0 | 142,100 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | A Award | 2019-06-05 | 2019-06-06 | 23,700 | — | $0 | 145,231 | SEC↗ |
| PCRX Pacira BioSciences, Inc. | S Sale | 2019-06-04 | 2019-06-06 | 12,385 | $42.91 | $531.4K | 121,531 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-05-29 | 2019-05-31 | 33,799 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-05-29 | 2019-05-31 | 33,799 | $3.21 | $108.5K | 33,799 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-05-29 | 2019-05-31 | 33,799 | $18.45 | $623.6K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 7,428 | — | $0 | 7,428 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2019-05-20 | 2019-05-21 | 9,658 | — | $0 | 9,658 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-05-17 | 2019-05-21 | 13,174 | — | $0 | 33,799 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-05-17 | 2019-05-21 | 13,174 | $3.21 | $42.3K | 13,174 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-05-17 | 2019-05-21 | 13,174 | $18.00 | $237.1K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 21,146 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 45,000 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 13,500 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 28,500 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 5,786 | — | $0 | 11,572 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise deriv | 2019-01-10 | 2019-01-11 | 11,572 | — | $0 | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 21,146 | $3.06 | $64.7K | 26,932 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 5,786 | $2.50 | $14.5K | 5,786 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 26,932 | $18.00 | $484.8K | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 45,000 | $9.34 | $420.3K | 45,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 28,500 | $1.87 | $53.3K | 87,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 13,500 | $5.58 | $75.3K | 58,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | S Sale | 2019-01-10 | 2019-01-11 | 98,572 | $18.00 | $1.77M | 0 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | M Exercise | 2019-01-10 | 2019-01-11 | 11,572 | $2.50 | $28.9K | 98,572 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-12-18 | 2018-12-20 | 6,000 | — | $0 | 59,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-12-18 | 2018-12-20 | 6,000 | — | $0 | 51,856 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-12-18 | 2018-12-20 | 6,000 | $5.49 | $32.9K | 133,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-12-18 | 2018-12-20 | 6,000 | $1.61 | $9.7K | 127,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-11-15 | 2018-11-19 | 4,558 | $47.70 | $217.4K | 121,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-11-15 | 2018-11-19 | 10,442 | $47.25 | $493.4K | 126,241 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-10-11 | 2018-10-15 | 18,190 | — | $0 | 65,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-10-11 | 2018-10-15 | 11,810 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-10-11 | 2018-10-15 | 15,000 | — | $0 | 57,856 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-10-11 | 2018-10-15 | 11,810 | $1.61 | $19.0K | 103,493 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-10-11 | 2018-10-15 | 15,000 | $5.49 | $82.3K | 136,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-10-11 | 2018-10-15 | 18,190 | $1.61 | $29.3K | 121,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-08-15 | 2018-08-16 | 610 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-08-15 | 2018-08-16 | 13,481 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-08-15 | 2018-08-16 | 13,481 | $10.81 | $145.7K | 124,745 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-08-15 | 2018-08-16 | 21,198 | $47.11 | $998.6K | 103,547 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-08-15 | 2018-08-16 | 11,864 | $47.69 | $565.8K | 91,683 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-08-15 | 2018-08-16 | 610 | $5.49 | $3.3K | 111,264 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2018-06-13 | 2018-06-15 | 170,250 | — | $0 | 170,250 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2018-06-13 | 2018-06-15 | 28,375 | — | $0 | 110,415 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2018-06-07 | 2018-06-11 | 13,000 | — | $0 | 13,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-06-07 | 2018-06-08 | 2,600 | $37.53 | $97.6K | 82,040 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-06-07 | 2018-06-08 | 7,191 | $36.63 | $263.4K | 84,640 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-06-06 | 2018-06-08 | 8,615 | $35.61 | $306.8K | 91,831 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-05-15 | 2018-05-17 | 15,000 | — | $0 | 610 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-05-15 | 2018-05-17 | 10,000 | — | $0 | 13,481 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-05-15 | 2018-05-17 | 21,106 | $33.69 | $711.1K | 104,340 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-05-15 | 2018-05-17 | 3,894 | $34.34 | $133.7K | 100,446 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-05-15 | 2018-05-17 | 15,000 | $5.49 | $82.3K | 115,446 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-05-15 | 2018-05-17 | 10,000 | $10.81 | $108.1K | 125,446 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 46,973 | — | $0 | 46,973 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2018-05-14 | 2018-10-02 | 31,153 | — | $0 | 31,153 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2018-01-10 | 2018-01-12 | 28,885 | — | $0 | 83,190 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-01-10 | 2018-01-12 | 4,628 | $41.03 | $189.9K | 101,331 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2018-01-10 | 2018-01-12 | 28,885 | $1.61 | $46.5K | 129,331 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-01-10 | 2018-01-12 | 885 | $41.97 | $37.1K | 100,446 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2018-01-10 | 2018-01-12 | 23,372 | $39.96 | $933.9K | 105,959 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-11-15 | 2017-11-17 | 28,885 | — | $0 | 112,075 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-11-15 | 2017-11-17 | 1,900 | $38.97 | $74.0K | 100,279 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-11-15 | 2017-11-17 | 56,985 | $38.32 | $2.18M | 102,179 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-11-15 | 2017-11-17 | 28,885 | $1.61 | $46.5K | 159,164 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-08-15 | 2017-08-17 | 28,885 | — | $0 | 11,810 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-08-15 | 2017-08-17 | 28,885 | $36.37 | $1.05M | 130,279 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-08-15 | 2017-08-17 | 28,885 | $1.61 | $46.5K | 159,164 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-07-24 | 2017-07-26 | 15,000 | — | $0 | 140,960 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-07-24 | 2017-07-26 | 15,000 | $1.61 | $24.1K | 130,279 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-06-23 | 2017-06-27 | 15,000 | — | $0 | 155,960 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-06-23 | 2017-06-27 | 15,000 | $1.61 | $24.1K | 115,059 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2017-06-15 | 2017-06-19 | 13,000 | — | $0 | 13,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2017-06-14 | 2017-06-16 | 81,000 | — | $0 | 81,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2017-06-14 | 2017-06-16 | 40,500 | — | $0 | 100,059 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-06-05 | 2017-06-07 | 4,311 | $43.32 | $186.8K | 59,559 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 14,706 | — | $0 | 14,706 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2017-05-15 | 2017-05-17 | 21,146 | — | $0 | 21,146 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2017-01-17 | 2017-01-19 | 15,000 | — | $0 | 15,610 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-01-17 | 2017-01-19 | 1,300 | $38.81 | $50.5K | 63,870 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-01-17 | 2017-01-19 | 13,700 | $38.37 | $525.7K | 65,170 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2017-01-17 | 2017-01-19 | 15,000 | $5.49 | $82.3K | 78,870 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-09 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-11-15 | 2016-11-17 | 15,000 | — | $0 | 30,610 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-11-15 | 2016-11-17 | 15,000 | $5.49 | $82.3K | 78,637 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-11-15 | 2016-11-17 | 1,800 | $37.76 | $68.0K | 63,637 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-11-15 | 2016-11-17 | 13,200 | $37.21 | $491.2K | 65,437 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-10-05 | 2016-10-07 | 30,000 | — | $0 | 40,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-10-05 | 2016-10-07 | 30,000 | $1.61 | $48.3K | 63,637 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-08-15 | 2016-08-17 | 15,000 | — | $0 | 45,610 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-08-15 | 2016-08-17 | 15,000 | $5.49 | $82.3K | 48,637 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-08-15 | 2016-08-17 | 15,000 | $45.32 | $679.8K | 33,637 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 28,847 | — | $0 | 28,847 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2016-07-11 | 2016-07-13 | 20,548 | — | $0 | 20,548 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-06-15 | 2016-06-17 | 66,250 | — | $0 | 66,250 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2016-06-15 | 2016-06-17 | 33,125 | — | $0 | 33,410 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2016-06-09 | 2016-06-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-04-15 | 2016-04-19 | 25,000 | — | $0 | 60,610 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-04-15 | 2016-04-19 | 25,000 | $5.49 | $137.3K | 25,285 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-04-15 | 2016-04-19 | 18,650 | $63.97 | $1.19M | 6,635 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-04-15 | 2016-04-19 | 6,350 | $64.62 | $410.3K | 285 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2016-01-15 | 2016-01-19 | 15,000 | — | $0 | 70,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-01-15 | 2016-01-19 | 1,000 | $62.55 | $62.5K | 14,285 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-01-15 | 2016-01-19 | 9,608 | $63.69 | $611.9K | 4,677 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2016-01-15 | 2016-01-19 | 4,392 | $64.46 | $283.1K | 285 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2016-01-15 | 2016-01-19 | 15,000 | $1.61 | $24.1K | 15,285 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-10-15 | 2015-10-19 | 15,000 | — | $0 | 85,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-10-15 | 2015-10-19 | 600 | $38.49 | $23.1K | 176 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-10-15 | 2015-10-19 | 7,799 | $37.89 | $295.5K | 776 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-10-15 | 2015-10-19 | 6,601 | $37.11 | $245.0K | 8,575 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-10-15 | 2015-10-19 | 15,000 | $1.61 | $24.1K | 15,176 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-07-15 | 2015-07-17 | 15,000 | — | $0 | 100,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-07-15 | 2015-07-17 | 15,000 | $67.78 | $1.02M | 176 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-07-15 | 2015-07-17 | 15,000 | $1.61 | $24.1K | 15,176 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 18,000 | — | $0 | 18,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 17,358 | — | $0 | 17,358 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 23,144 | — | $0 | 23,144 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2015-07-06 | 2015-07-08 | 40,500 | — | $0 | 40,500 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-04-15 | 2015-04-17 | 25,000 | — | $0 | 115,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-04-15 | 2015-04-17 | 25,000 | $1.61 | $40.3K | 25,059 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-04-15 | 2015-04-17 | 25,000 | $90.50 | $2.26M | 59 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2015-01-15 | 2015-01-20 | 15,000 | — | $0 | 140,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-01-15 | 2015-01-20 | 10,900 | $97.30 | $1.06M | 5,367 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-01-15 | 2015-01-20 | 1,600 | $98.74 | $158.0K | 1,267 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2015-01-15 | 2015-01-20 | 15,000 | $1.61 | $24.1K | 16,267 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2015-01-15 | 2015-01-20 | 2,500 | $97.71 | $244.3K | 2,867 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-10-15 | 2014-10-17 | 15,000 | — | $0 | 170,960 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-10-15 | 2014-10-17 | 600 | $97.74 | $58.6K | 15,308 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-10-15 | 2014-10-17 | 7,485 | $99.80 | $747.0K | 2,406 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-10-15 | 2014-10-17 | 5,417 | $99.05 | $536.6K | 9,891 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-10-15 | 2014-10-17 | 1,198 | $101.20 | $121.2K | 1,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-10-15 | 2014-10-17 | 300 | $96.60 | $29.0K | 15,908 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-10-15 | 2014-10-17 | 15,000 | $1.61 | $24.1K | 16,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | G Gift deriv | 2014-09-09 | 2014-10-17 | 350,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | G Gift deriv | 2014-09-09 | 2014-10-17 | 350,000 | — | $0 | 350,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | G Gift deriv | 2014-09-09 | 2014-10-17 | 150,000 | — | $0 | 0 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | G Gift deriv | 2014-09-09 | 2014-10-17 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-07-15 | 2014-07-16 | 15,000 | — | $0 | 155,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-07-15 | 2014-07-16 | 15,000 | $1.61 | $24.1K | 16,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-07-15 | 2014-07-16 | 1,000 | $88.23 | $88.2K | 1,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-07-15 | 2014-07-16 | 6,600 | $87.05 | $574.5K | 2,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-07-15 | 2014-07-16 | 7,400 | $86.28 | $638.5K | 8,808 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2014-06-03 | 2014-06-05 | 150,000 | — | $0 | 150,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2014-05-09 | 2014-05-09 | 25,000 | — | $0 | 170,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2014-05-09 | 2014-05-09 | 25,000 | $1.61 | $40.3K | 26,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-09 | 2014-05-09 | 7,400 | $73.40 | $543.2K | 18,808 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-09 | 2014-05-09 | 300 | $74.80 | $22.4K | 1,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2014-05-09 | 2014-05-09 | 17,300 | $74.15 | $1.28M | 1,508 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 28,500 | — | $0 | 28,500 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2014-03-11 | 2014-03-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2014-03-11 | 2014-03-13 | 221 | — | $0 | 1,208 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-12-30 | 2014-01-02 | 15,000 | — | $0 | 195,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-12-30 | 2014-01-02 | 15,000 | $55.84 | $837.6K | 2,987 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-12-30 | 2014-01-02 | 15,000 | $1.61 | $24.1K | 17,987 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-11-18 | 2013-11-20 | 414 | — | $0 | 2,987 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-09-30 | 2013-10-02 | 15,000 | — | $0 | 210,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-09-30 | 2013-10-02 | 1,094 | $47.55 | $52.0K | 2,573 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-09-30 | 2013-10-02 | 13,906 | $47.01 | $653.7K | 3,667 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-09-30 | 2013-10-02 | 15,000 | $1.61 | $24.1K | 17,573 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2013-07-09 | 2013-07-11 | 13,500 | — | $0 | 13,500 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-06-28 | 2013-07-02 | 15,000 | — | $0 | 225,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-06-28 | 2013-07-02 | 15,000 | $1.61 | $24.1K | 17,573 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-06-28 | 2013-07-02 | 15,000 | $28.73 | $430.9K | 2,573 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise deriv | 2013-03-28 | 2013-04-01 | 15,000 | — | $0 | 240,695 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2013-03-28 | 2013-04-01 | 15,000 | $28.66 | $429.9K | 2,573 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | M Exercise | 2013-03-28 | 2013-04-01 | 15,000 | $1.61 | $24.1K | 17,573 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | J Other | 2013-03-18 | 2013-03-25 | 573 | — | $0 | 2,573 | SEC↗ |
| AMRN AMARIN CORP PLC\UK | A Award deriv | 2012-12-10 | 2012-12-12 | 45,000 | — | $0 | 45,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2012-06-05 | 2012-06-07 | 350,000 | — | $0 | 350,000 | SEC↗ |